NON-ALCOHOLIC STEATOHEPATITIS (NASH)
Clinical trials for NON-ALCOHOLIC STEATOHEPATITIS (NASH) explained in plain language.
Never miss a new study
Get alerted when new NON-ALCOHOLIC STEATOHEPATITIS (NASH) trials appear
Sign up with your email to follow new studies for NON-ALCOHOLIC STEATOHEPATITIS (NASH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could special ice cream help manage blood sugar?
Disease control OngoingThis study is testing whether two types of specially formulated ice cream can help control blood sugar and improve digestion for people with non-alcoholic fatty liver disease (NASH) and type 2 diabetes. One hundred participants will eat portions of the special ice creams and a re…
Matched conditions: NON-ALCOHOLIC STEATOHEPATITIS (NASH)
Phase: NA • Sponsor: Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New weekly shot aims to tackle obesity and diabetes
Disease control OngoingThis study is testing the safety and effects of a new weekly injection called AZD9550, both by itself and combined with another drug, AZD6234. It involves about 118 adults who are overweight or have obesity, some with and some without type 2 diabetes. The main goals are to see ho…
Matched conditions: NON-ALCOHOLIC STEATOHEPATITIS (NASH)
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Stomach-Stitching procedure could reverse scarring in deadly liver disease
Disease control OngoingThis study is testing whether a minimally invasive stomach-shrinking procedure can treat advanced fatty liver disease (NASH) in people with obesity. Researchers will perform the endoscopic sleeve gastroplasty procedure on 20 participants and measure changes in liver scarring, fat…
Matched conditions: NON-ALCOHOLIC STEATOHEPATITIS (NASH)
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
14-Second scan could replace painful liver biopsies
Diagnosis OngoingThis study is testing a new type of MRI scan designed to diagnose a serious form of fatty liver disease called NASH. The goal is to see if this quick, 14-second scan can accurately measure liver fat, inflammation, and scarring without needing a painful needle biopsy. Researchers …
Matched conditions: NON-ALCOHOLIC STEATOHEPATITIS (NASH)
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Apr 02, 2026 03:41 UTC
-
Could a simple scan replace painful liver biopsies?
Diagnosis OngoingThis study is testing a new type of PET scan to see if it can accurately measure fat, inflammation, and scarring in the liver. It aims to provide a clearer picture of fatty liver disease without needing a painful biopsy. The study involves 120 adults who are already scheduled for…
Matched conditions: NON-ALCOHOLIC STEATOHEPATITIS (NASH)
Sponsor: University of California, Davis • Aim: Diagnosis
Last updated Mar 10, 2026 12:52 UTC